Dimensional Fund Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.65M | Buy |
673,884
+9,149
| +1% | +$104K | ﹤0.01% | 2375 |
|
|
2025
Q1 | $4.42M | Buy |
664,735
+125,835
| +23% | +$837K | ﹤0.01% | 2531 |
|
|
2024
Q4 | $5.94M | Buy |
538,900
+273,890
| +103% | +$3.02M | ﹤0.01% | 2486 |
|
|
2024
Q3 | $3.26M | Buy |
265,010
+73,650
| +38% | +$905K | ﹤0.01% | 2660 |
|
|
2024
Q2 | $2.58M | Sell |
191,360
-28,405
| -13% | -$384K | ﹤0.01% | 2698 |
|
|
2024
Q1 | $2.97M | Buy |
219,765
+4,471
| +2% | +$60.4K | ﹤0.01% | 2692 |
|
|
2023
Q4 | $1.13M | Sell |
215,294
-43,128
| -17% | -$227K | ﹤0.01% | 2905 |
|
|
2023
Q3 | $1.02M | Sell |
258,422
-81,723
| -24% | -$322K | ﹤0.01% | 2924 |
|
|
2023
Q2 | $3.62M | Buy |
340,145
+46,513
| +16% | +$494K | ﹤0.01% | 2622 |
|
|
2023
Q1 | $2.45M | Buy |
293,632
+1,625
| +0.6% | +$13.5K | ﹤0.01% | 2694 |
|
|
2022
Q4 | $2.7K | Sell |
292,007
-46,989
| -14% | -$434 | ﹤0.01% | 2642 |
|
|
2022
Q3 | $4.35M | Buy |
338,996
+73,975
| +28% | +$950K | ﹤0.01% | 2476 |
|
|
2022
Q2 | $3.5M | Buy |
265,021
+113,361
| +75% | +$1.5M | ﹤0.01% | 2560 |
|
|
2022
Q1 | $3.19M | Buy |
151,660
+79,518
| +110% | +$1.67M | ﹤0.01% | 2682 |
|
|
2021
Q4 | $1.73M | Buy |
72,142
+27,423
| +61% | +$658K | ﹤0.01% | 2884 |
|
|
2021
Q3 | $1.14M | Sell |
44,719
-60,664
| -58% | -$1.54M | ﹤0.01% | 3018 |
|
|
2021
Q2 | $3.55M | Sell |
105,383
-3,440
| -3% | -$116K | ﹤0.01% | 2705 |
|
|
2021
Q1 | $4.22M | Buy |
108,823
+69,010
| +173% | +$2.67M | ﹤0.01% | 2633 |
|
|
2020
Q4 | $2.47M | Buy |
39,813
+32,432
| +439% | +$2.01M | ﹤0.01% | 2751 |
|
|
2020
Q3 | $247K | Buy |
+7,381
| New | +$247K | ﹤0.01% | 3181 |
|